New definition of obesity proposed by World Health Organization

A newly proposed definition of obesity could see more people classified as obese, sparking concerns about the accuracy of current assessments.

The World Health Organization defines obesity as a body mass index (BMI) of 30 or higher, but critics argue that this metric is too simplistic and fails to account for individual variations in body composition.

According to Dr. Francesco Rubino, a professor at King's College London, BMI "misses a lot of information" when it comes to assessing patients' health risks.

Rubino chaired a team of experts that developed new diagnostic criteria for obesity, which include more detailed measurements beyond just BMI.

The new framework distinguishes between preclinical and clinical obesity, with the former referring to individuals who are at risk of developing obesity-related health problems but have not yet done so.

This distinction is crucial because it allows healthcare professionals to identify patients who need early intervention before their condition worsens.

While BMI provides a general guideline for assessing obesity, it has its limitations in accurately measuring an individual's health risk.

BMI does not account for variations in lean muscle mass and bone density among individuals, which can lead to inaccurate assessments of a person's body fat percentage.

This oversight can be particularly problematic when evaluating patients from different racial or ethnic backgrounds, as some groups tend to experience adverse health consequences at lower BMI levels than others.

For instance, certain populations may develop serious health issues at a BMI that would be classified as normal in another group.

To provide a more accurate assessment of obesity, the proposed new definition suggests using additional body measurements alongside BMI.

The proposed new definition of obesity takes into account not just body mass index (BMI), but also other measurements such as waist circumference and ratio. Different ethnic groups have varying fat distribution patterns in the body, so the study considered different waist circumference cutoffs for each group.

Waist-to-hip and waist-to-height ratios are also being considered alongside BMI to provide a more accurate assessment of obesity. These additional measurements can help identify individuals at risk of developing obesity-related health problems.

The new definition also looks at 18 conditions and signs of bodily or organ dysfunction associated with excess fat tissue, such as cardiovascular diseases, joint pain and sleep apnea. These conditions are used to define "clinical obesity" as a disease state that involves at least one of these forms of dysfunction caused by excess fat tissue.

Preclinical obesity refers to individuals who are at risk of developing clinical obesity and may need interventions to avoid related health problems. The distinction between preclinical and clinical obesity can be complex, as the diagnostic metrics for each form of dysfunction contain their own ambiguities.

Studies have shown that a significant proportion of individuals with preclinical obesity do not progress to clinical obesity within a certain timeframe, such as 10 years. However, the exact percentage varies depending on the cohort analyzed, suggesting that more research is needed to understand this relationship.

The proposed new definition of clinical obesity could lead to a higher number of individuals being classified as obese, according to researchers from The Lancet Commission.

This shift in diagnostic criteria may also have implications for treatment recommendations, particularly regarding weight-control medications.

A recent analysis by Dr. Aayush Visaria found that the categories of preclinical and clinical obesity can help doctors identify patients who require urgent attention.

The study used electronic health records from various countries to track health outcomes associated with different levels of obesity.

By examining these data, researchers discovered a significant correlation between clinical obesity and increased mortality risk.

The proposed new definition for obesity would categorize individuals based on their body mass index (BMI) and the presence or absence of related health issues.

In contrast to the current approach, which considers a BMI of 30 or higher as obese, this new framework takes into account other factors such as metabolic dysfunction and excess fat in various parts of the body.

Researchers predict that some individuals with BMIs under 30 would be reclassified as clinically obese due to related health issues, while others with high BMIs but no dysfunction would not be considered obese under this new definition.

The exact percentage of people affected by this change varies depending on the group being analyzed, but it is estimated to be around a few percent in some cases.

Implementing this new definition would require further research to confirm its effectiveness and practicality in clinical settings.

Implementing a new definition of obesity would require clinicians to be trained in accurately measuring body mass index and waist circumference using specific techniques.

The distinction between preclinical and clinical obesity may also pose challenges for healthcare providers, who could struggle with the implications of recharacterizing patients who currently qualify for obesity medications under FDA guidelines.

Developments are underway to further validate the framework proposed by the Lancet Commission, which aims to provide a more nuanced approach to personalized obesity treatment.